Home » Topics » BioWorld Science

BioWorld Science
RSS

Fournier investigates deoxyspergualin analogues

Oct. 4, 1996

Enzyme inhibitor for autoimmune diseases isolated by Japanese researchers

Oct. 4, 1996

Mercian investigators report new antiarthritic compounds

Oct. 4, 1996

Merck Frosst discloses a new series of COX-2 inhibitors

Oct. 4, 1996

Matrix metalloproteinase inhibitors disclosed by Roche Bioscience

Oct. 4, 1996

More COX-2 inhibitors from Searle

Oct. 4, 1996

Gilead Sciences issues warning regarding Vistide

Oct. 4, 1996

Japanese patent coverage for NABI HIV immunotherapeutic

Oct. 4, 1996

New agent for CMV infection from Glaxo Wellcome

Oct. 4, 1996

Pharmacia & Upjohn details the activity of new HIV protease inhibitor

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026